Glenmark Of India Tests Drug Plant With Aim For U.S. Approval
This article was originally published in PharmAsia News
Executive Summary
India's Glenmark Pharmaceuticals has begun test-production of pharmaceutical products at a new plant in Indore with the aim of receiving U.S. FDA approval